HBsAg clearance and seroconversion case in a patient with HBeAg-negative chronic hepatitis B on pegylated interferon α-2a therapy
Presented clinical case describes elimination followed by seroconversion HBsAg / HBsAb patient with HBeAg-negative chronic hepatitis B on antiviral therapy with pegylated interferon α2-a and achieving sustained virological response.
Saved in:
Main Authors: | K. V. Zhdanov, D. A. Gusev, K. V. Kozlov, S. S. Zhabrov, A. V. Shekurov, A. V. Nagovitsyn, A. V. Mishin, E. V. Jakovleva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Journal Infectology
2014-09-01
|
Series: | Журнал инфектологии |
Subjects: | |
Online Access: | https://journal.niidi.ru/jofin/article/view/243 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment
by: Shengxia Yin, et al.
Published: (2023-12-01) -
High HBsAg clearance rate and viral dynamics in HBeAg-positive, ALT-normal children and adolescents with chronic HBV infection: results from the prospective sprout project
by: Xin Wang, et al.
Published: (2025-12-01) -
Steatosis and Interferon Associated with HBsAg Immune Control in Chronic Hepatitis B: A Real-World Propensity Score-Matched Study
by: Qi Xu, et al.
Published: (2025-06-01) -
Protracted HBsAg-aemia in a Patient with Acute Hepatitis B
by: K. R. Dudina, et al.
Published: (2018-11-01) -
Clinical laboratory characteristic of hospitalized patients with HBsAg negative chronic hepatitis B
by: E. O. Shibaeva, et al.
Published: (2014-09-01)